Molnupiravir, an oral COVID-19 antiviral medication, has just been added as a conditional recommendation to the World Health Organization’s living guidelines on COVID-19 therapeutics.  The pill, created by Merck, had already been approved by the Medicines Patent Pool (MPP) in January to be distributed and supplied in 105 low- and middle-income countries (LMICs).  In comparison […] Continue reading ->
Within one year, Africa has gone from waiting for its first COVID-19 vaccine shipment from the WHO-supported global COVAX facility to having excess doses available that some countries are  struggling roll out efficiently.  Reflections on the first anniversary of the massive COVAX vaccine rollout.  On 24 February 2021, Health Policy Watch reported the global COVAX […] Continue reading ->
Individuals who recovered from COVID-19 and then received at least one shot of the Pfizer mRNA COVID-19 vaccine had a significantly lower risk of reinfection, according to a new study published Wednesday’s New England Journal of Medicine,. The study was conducted by researchers at Israel’s Clalit Health Services, in collaboration with Ben-Gurion University and Sapir […] Continue reading ->
Two years after the COVID-19 pandemic began, over ninety percent of countries continue to face ongoing disruptions to their health systems, according to a survey published Monday evening by the World Health Organization. The WHO Global Pulse Survey, the third of its kind since the start of the COVID-19 crisis, analysed responses from 129 countries, […] Continue reading ->